Vyleesi® product results: 14% growth in prescriptions dispensed over prior quarter – 7 consecutive quarters of double digit growth. Click here to learn more ›

Probing the Role of the Melanocortin Receptor Agonists in Experimental Immune-Mediated Diseases

Scroll to Top